ABCA-1 elevating compounds against coronary artery disease or atherosclerosis

Details for Australian Patent Application No. 2002225978 (hide)

International Classifications

Event Publications

11 August 2005 Application Accepted

Published as AU-B-2002225978

8 December 2005 Standard Patent Sealed

15 October 2009 Amendment Made

The nature of the amendment is: Amend the patentee name from CV Therapeutics, Inc. to Gilead Palo Alto, Inc.

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.